Osteopontin is associated with nuclear factor κB gene expression during tail-suspension-induced bone loss

被引:46
作者
Ishijima, Muneaki
Ezura, Yoichi
Tsuji, Kunikazu
Rittling, Susan R.
Kurosawa, Hisashi
Denhardt, David T.
Emi, Mitsuru
Nifuji, Akira
Noda, Masaki
机构
[1] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Chiyoda Ku, Tokyo 1010062, Japan
[2] Rutgers State Univ, Nelson Labs, Piscataway, NJ 08854 USA
[3] Forsyth Inst, Boston, MA 02115 USA
[4] Nippon Med Sch, Inst Gerontol, Dept Mol Biol, Kawasaki, Kanagawa, Japan
[5] Juntendo Univ, Sch Med, Dept Orthopaed, Tokyo 1138421, Japan
[6] Tokyo Med & Dent Univ, 21st Century Ctr Excellence COE, Program Mol Destruct & Reconstruct Tooth & Bone, Tokyo 1010062, Japan
[7] Tokyo Med & Dent Univ, Japan Soc Promot Sci, Core Core Program Adv Bone & Joint Sci, Tokyo 1010062, Japan
[8] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo 1010062, Japan
关键词
osteopontin; mechanical loading; rodent; array; stromal cell;
D O I
10.1016/j.yexcr.2006.06.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Osteoporosis due to unloading-induced bone loss is a critical issue in the modem aging society. Although the mechanisms underlying this phenomenon are largely unknown, osteopontin (OPN) is one of the critical mediators required for unloading-induced bone loss [M. Ishijima, S.R. Rittling, T. Yamashita, K. Tsuji, H. Kurosawa, A. Nifuji, D.T. Denhardt, and M. Noda, Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin, J Exp Med, 193 (2001) 399-404]. To clarify the molecular bases for OPN actions, we carried out microarray analyses on the genes expressed in the femoral bone marrow cells in wild type and OPN-/- mice. The removal of the mechanical load induced bone loss in wild type, but not in OPN-/- mice, as previously reported. Expression analysis of 9586 cDNAs on a microarray system revealed that OPN deficiency blocked tail-suspension-induced expression of ten genes (group A). This observation was confirmed based on semi-quantitative RT-PCR analyses. On the other hand, expression of four genes (group B) was not altered by tail suspension in wild type but was enhanced in OPN-deficient mice. NF-kappa B p105 subunit gene (Nfkb1) was found in group A and Bax in group B. p53 gene expression was upregulated by tail suspension in wild type mice, but it was no longer observed in OPN-/- mice. These data indicate that OPN acts to mediate mechanical stress signaling upstream to the genes encoding apoptosis-related molecules, and its action is associated with alteration of the genes. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:3075 / 3083
页数:9
相关论文
共 43 条
[1]
[Anonymous], NAT MED
[2]
Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone [J].
Asou, Y ;
Rittling, SR ;
Yoshitake, H ;
Tsuji, K ;
Shinomiya, K ;
Nifuji, A ;
Denhardt, DT ;
Noda, M .
ENDOCRINOLOGY, 2001, 142 (03) :1325-1332
[3]
Mechanotransduction in bone - role of the lacuno-canalicular network [J].
Burger, EH ;
Klein-Nulend, J .
FASEB JOURNAL, 1999, 13 :S101-S112
[4]
Mechanotransduction in response to shear stress - Roles of receptor tyrosine kinases, integrins, and Shc [J].
Chen, KD ;
Li, YS ;
Kim, M ;
Li, S ;
Yuan, S ;
Chien, S ;
Shyy, JYJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18393-18400
[5]
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[6]
CULLINANE DM, 2002, BIOMECHANICS BONE PR
[7]
Osteopontin stimulates cell motility and nuclear factor κB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells [J].
Das, R ;
Mahabeleshwar, GH ;
Kundu, GC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (31) :28593-28606
[8]
Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO
[9]
2-A
[10]
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival [J].
Denhardt, DT ;
Noda, M ;
O'Regan, AW ;
Pavlin, D ;
Berman, JS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (09) :1055-1061